NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/12/2022
Voltar para busca
Dado oficial do USPTO
SYBODY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
18/12/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
20/12/2019
Data de registro
30/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/11/2021
Última transação
30/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH
Examinador
LAM, HAI-LY
Unidade examinadora
N10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Linkster Therapeutics AG
R. D. (pessoa física)
I. Z. (pessoa física)
P. E. (pessoa física)
Representantes
Julie Reitz Honigman LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for scientific and research purposes; diagnostic reagents for scientific and research purposes; diagnostic preparations for scientific use, namely, molecules, antibodies, nanobodies, peptides, target molecules; chemical and biochemical substances for in vitro and in vivo scientific use; chemical materials, namely, chemical agents for chelating and sequestering, rheology modifiers for use in the field of coating materials and chemical preparations, namely, chemical preparations for scientific purposes, industrial chemicals and natural elements, namely, diamond molecules for use in pharmaceuticals
Classe 5
Pharmaceutical preparations, namely, novel therapeutic antibodies; medical and veterinary preparations in the nature of vaccines; bacterial preparations for medical and veterinary use; medical preparations for the treatment of gout; veterinary preparations for treatment of intestinal bacteria; hygienic products for medical use, namely, disinfectants for medical hygienic purposes; all of the aforementioned exclude vitamin supplements
Classe 42
Scientific research services for identification and quantification of molecules, in particular polypeptides, from a series of molecules; scientific research services using a series of bar codes for identifying molecules selected by mass spectrometry; scientific analyses in the field of molecular biology; consultancy in the field of technological research in the area of diagnostic preparations; scientific advice relating to research and development in the field of therapeutic procedures; consulting services in the field of pharmaceutical research; consulting services for gene therapy research; provision of scientific information and data relating to medical and veterinary product research and development; biochemical and biotechnological research and development; research, testing and computer-aided scientific analysis in the field of pharmaceuticals and biochemicals; scientific research in the field of proteins, antibodies, microorganisms and cells; computer software development
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/05/2022
FIMP
FINAL DISPOSITION PROCESSED
18/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
30/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/09/2021
PUBO
PUBLISHED FOR OPPOSITION
14/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/08/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/08/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/07/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/07/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/02/2021
GNFR
FINAL REFUSAL E-MAILED
09/02/2021
CNFR
FINAL REFUSAL WRITTEN
09/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/01/2021
ALIE
ASSIGNED TO LIE
07/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/09/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
13/08/2020
RFNT
REFUSAL PROCESSED BY IB
24/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/04/2020
RFRR
REFUSAL PROCESSED BY MPU
08/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/03/2020
CNRT
NON-FINAL ACTION WRITTEN
20/03/2020
DOCK
ASSIGNED TO EXAMINER
18/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/02/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYBODY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.